Senores Pharmaceuticals Ltd Quarterly Results

Gross Sales

114.21

103.02

102.44

78.7

Excise Duty

0

0

0

0

Net Sales

114.21

103.02

102.44

78.7

Other Operating Income

0

0

0

0

Other Income

11.77

5.16

1.96

0.8

Total Income

125.98

108.18

104.4

79.5

Total Expenditure

94.77

77.33

80.05

63.55

PBIDT

31.21

30.85

24.35

15.95

Interest

5.3

6.16

3.03

2.45

PBDT

25.91

24.69

21.32

13.5

Depreciation

5.23

4.2

3.71

3.25

Minority Interest Before NP

0

0

0

0

Tax

6.73

6.1

5.96

2.68

Deferred Tax

-4.02

-2.04

-2.53

0.46

Reported Profit After Tax

17.97

16.43

14.18

7.11

Minority Interest After NP

0.14

-0.75

-1.76

0.01

Net Profit after Minority Interest

17.83

17.18

15.94

7.1

Extra-ordinary Items

0

0

0

0

Adjusted Profit After Extra-ordinary item

17.83

17.18

15.94

7.1

EPS (Unit Curr.)

3.81

5.04

8.03

4.01

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

0

0

0

0

Equity

46.05

46.05

30.51

29.95

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

27.32

29.94

23.77

20.26

PBDTM(%)

22.68

23.96

20.81

17.15

PATM(%)

15.73

15.94

13.84

9.03